Stay updated on Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s revision/version indicator updates from v3.5.2 to v3.5.3, reflecting a publishing or site release change without affecting the study record content.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a routine version/UI update and does not modify study details or eligibility on the page.SummaryDifference0.1%

- Check83 days agoChange DetectedSite update deployed Revision v3.4.2 and removed the funding-lapse notice and Revision v3.4.1; these are administrative changes and do not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check90 days agoChange DetectedNotice about a lapse in government funding and a new site revision tag (v3.4.1) were added, while the previous revision tag (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Rilsodotin+Carboplatin in Ovarian Cancer Clinical Trial page.